Sabra Health Care REIT (SBRA) to Release Quarterly Earnings on Monday

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) will likely be announcing its Q1 2025 earnings results after the market closes on Monday, May 5th. Analysts expect Sabra Health Care REIT to post earnings of $0.36 per share and revenue of $180.23 million for the quarter. Sabra Health Care REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. The firm had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. On average, analysts expect Sabra Health Care REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Health Care REIT Stock Down 1.1 %

Shares of Sabra Health Care REIT stock traded down $0.20 during midday trading on Friday, hitting $17.42. The company had a trading volume of 1,990,457 shares, compared to its average volume of 2,144,094. Sabra Health Care REIT has a 52-week low of $13.87 and a 52-week high of $20.03. The stock has a market capitalization of $4.14 billion, a P/E ratio of 32.87, a P/E/G ratio of 1.97 and a beta of 0.88. The company has a 50 day moving average of $17.27 and a 200 day moving average of $17.51. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.89%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT's dividend payout ratio (DPR) is 226.42%.

Analyst Ratings Changes

A number of research firms have recently commented on SBRA. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Truist Financial lifted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Finally, JMP Securities raised Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.